Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: Rapid response to treatment with caspofungin and itraconazole

Clinical Infectious Diseases

Volumn 34, Issue 10, 2002, Pages 1415-1417

  Safdar, Amar ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; ITRACONAZOLE;

ADULT; ADVANCED CANCER; ANTIFUNGAL ACTIVITY; ARTICLE; CASE REPORT; DERMATOMYCOSIS; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INFECTION RISK; PAECILOMYCES LILACINUS; PANCREAS CANCER; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ITRACONAZOLE; MIDDLE AGED; MYCOSES; PAECILOMYCES; PEPTIDES; PEPTIDES, CYCLIC; TREATMENT OUTCOME;

EID: 0037093823     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340260     Document Type: Article

References (17)

1. Exogenous endophthalmitis caused by amphotericin B-resistant Paecilomyces lilacinus: Treatment options and visual outcomes
2. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed
3. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine
4. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: Case report and review
5. Paecilomyces variotii peritonitis in an infant on automated peritoneal dialysis
6. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in a renal transplant patient
7. A phase I study of caspofungin evaluating the potential for drug interactions with itraconazole, the effect of gender and the use of a loading dose regimen
8. Efficacy of LY303366 (LY) in ice with itraconazole (ITRA)-resistant aspergillosis
9. The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity Aspergillus fumigatus
10. Cutaneous mycosis caused by Paecilomyces lilacinus
11. Sporotrichosis-like lesions caused by a Paecilomyces genus fungus
12. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dermatiaceous fungi
13. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
14. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: Treatment with voriconazole
15. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp
16. Use of a novel real-time PCR assay to demonstrate efficacy of caspofungin, alone and in combination with amphotericin B, in reducing Aspergillus fumigatus tissue burden in chronically immunosuppressed mice with disseminated infection